Imalux Awarded $2.3 Million Research Grant
CLEVELAND--(BUSINESS WIRE)--Imalux Corporation (“Imalux”), a medical device company and developer of the Niris™ Imaging System based on Optical Coherence Tomography (“OCT”) technology, today announced the receipt of a Fast-Track research grant from the National Cancer Institute of the National Institutes of Health. The award of up to $2.3 million is to fund Imalux’s accelerated development of video rate Optical Coherence Tomography for early stage cance
Read Full Article
Login to comment.